Front-line doublets in advanced non-small cell lung cancer: The golden age for second line chemotherapy

Ann Oncol. 2005 Jul;16(7):997-8. doi: 10.1093/annonc/mdi231. Epub 2005 Jun 9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / physiopathology
  • Cisplatin / administration & dosage
  • Disease Progression
  • Docetaxel
  • Etoposide / administration & dosage
  • Female
  • Glutamates / administration & dosage
  • Guanine / administration & dosage
  • Guanine / analogs & derivatives
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / physiopathology
  • Male
  • Paclitaxel / administration & dosage
  • Pemetrexed
  • Survival Rate
  • Taxoids / administration & dosage

Substances

  • Glutamates
  • Taxoids
  • Pemetrexed
  • Docetaxel
  • Guanine
  • Etoposide
  • Carboplatin
  • Paclitaxel
  • Cisplatin